204 related articles for article (PubMed ID: 24228091)
1. Expression and clinical significance of the nin one binding protein and p38 MAPK in prostate carcinoma.
Che JP; Li W; Yan Y; Liu M; Wang GC; Li QY; Yang B; Yao XD; Zheng JH
Int J Clin Exp Pathol; 2013; 6(11):2300-11. PubMed ID: 24228091
[TBL] [Abstract][Full Text] [Related]
2. Nin one binding protein expression as a prognostic marker in prostate carcinoma.
Liu G; Shen D; Jiao L; Sun Y
Clin Transl Oncol; 2014 Sep; 16(9):843-7. PubMed ID: 24493285
[TBL] [Abstract][Full Text] [Related]
3. Positive nin one binding protein expression predicts poor outcome in prostate cancer.
Chen J; Wang J; Cui X; Liu Y; Yin L; Li Y; Chen L; Xu D; Gao Y
Mol Med Rep; 2015 Apr; 11(4):2671-6. PubMed ID: 25503472
[TBL] [Abstract][Full Text] [Related]
4. Downregulated miR-646 in clear cell renal carcinoma correlated with tumour metastasis by targeting the nin one binding protein (NOB1).
Li W; Liu M; Feng Y; Xu YF; Huang YF; Che JP; Wang GC; Yao XD; Zheng JH
Br J Cancer; 2014 Sep; 111(6):1188-200. PubMed ID: 25010867
[TBL] [Abstract][Full Text] [Related]
5. Down-regulation of protein kinase, DNA-activated, catalytic polypeptide attenuates tumor progression and is an independent prognostic predictor of survival in prostate cancer.
Zhang X; Wang Y; Ning Y
Urol Oncol; 2017 Mar; 35(3):111.e15-111.e23. PubMed ID: 27856181
[TBL] [Abstract][Full Text] [Related]
6. Adenovirus-mediated siRNA targeting NOB1 inhibits tumor growth and enhances radiosensitivity of human papillary thyroid carcinoma in vitro and in vivo.
Meng W; Wang PS; Liu J; Xue S; Wang GM; Meng XY; Chen G
Oncol Rep; 2014 Dec; 32(6):2411-20. PubMed ID: 25231838
[TBL] [Abstract][Full Text] [Related]
7. MiR-192 suppresses the tumorigenicity of prostate cancer cells by targeting and inhibiting nin one binding protein.
Sun J; Fan Z; Lu S; Yang J; Hao T; Huo Q
Int J Mol Med; 2016 Feb; 37(2):485-92. PubMed ID: 26743688
[TBL] [Abstract][Full Text] [Related]
8. Clinical significance of NOB1 expression in breast infiltrating ductal carcinoma.
Li XY; Luo QF; Li J; Wei CK; Kong XJ; Zhang JF; Fang L
Int J Clin Exp Pathol; 2013; 6(10):2137-44. PubMed ID: 24133592
[TBL] [Abstract][Full Text] [Related]
9. Silencing NOB1 enhances doxorubicin antitumor activity of the papillary thyroid carcinoma in vitro and in vivo.
Liu J; Dong BF; Wang PS; Ren PY; Xue S; Zhang XΝ; Han Z; Chen G
Oncol Rep; 2015 Mar; 33(3):1551-9. PubMed ID: 25592304
[TBL] [Abstract][Full Text] [Related]
10. Knockdown of NOB1 expression inhibits the malignant transformation of human prostate cancer cells.
Zhang X; Zhang D; Qu F; Hong Y; Cao J; Pan X; Li L; Huang Y; Huang H; Yin L; Chen L; Ren J; Wang Z; Xu D; Cui X
Mol Cell Biochem; 2014 Nov; 396(1-2):1-8. PubMed ID: 25169742
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of NIN/RPN12 binding protein inhibits proliferation and growth in human renal cancer cells.
Jia JW; Liu AQ; Wang Y; Zhao F; Jiao LL; Tan J
Tumour Biol; 2015 Mar; 36(3):1803-10. PubMed ID: 25420906
[TBL] [Abstract][Full Text] [Related]
12. A TMEFF2-regulated cell cycle derived gene signature is prognostic of recurrence risk in prostate cancer.
Georgescu C; Corbin JM; Thibivilliers S; Webb ZD; Zhao YD; Koster J; Fung KM; Asch AS; Wren JD; Ruiz-Echevarría MJ
BMC Cancer; 2019 May; 19(1):423. PubMed ID: 31060542
[TBL] [Abstract][Full Text] [Related]
13. NOB1 is essential for the survival of RKO colorectal cancer cells.
He XW; Feng T; Yin QL; Jian YW; Liu T
World J Gastroenterol; 2015 Jan; 21(3):868-77. PubMed ID: 25624720
[TBL] [Abstract][Full Text] [Related]
14. Low-Molecular-Weight Protein Tyrosine Phosphatase Predicts Prostate Cancer Outcome by Increasing the Metastatic Potential.
Ruela-de-Sousa RR; Hoekstra E; Hoogland AM; Souza Queiroz KC; Peppelenbosch MP; Stubbs AP; Pelizzaro-Rocha K; van Leenders GJLH; Jenster G; Aoyama H; Ferreira CV; Fuhler GM
Eur Urol; 2016 Apr; 69(4):710-719. PubMed ID: 26159288
[TBL] [Abstract][Full Text] [Related]
15. MicroRNA-326 functions as a tumor suppressor in glioma by targeting the Nin one binding protein (NOB1).
Zhou J; Xu T; Yan Y; Qin R; Wang H; Zhang X; Huang Y; Wang Y; Lu Y; Fu D; Chen J
PLoS One; 2013; 8(7):e68469. PubMed ID: 23869222
[TBL] [Abstract][Full Text] [Related]
16. Relationship between NOB1 expression and prognosis of resected non-small cell lung cancer.
Liu K; Chen HL; Gu MM; You QS
Int J Biol Markers; 2015 Feb; 30(1):e43-8. PubMed ID: 25450647
[TBL] [Abstract][Full Text] [Related]
17. Overexpression of high mobility group box 1 with poor prognosis in patients after radical prostatectomy.
Li T; Gui Y; Yuan T; Liao G; Bian C; Jiang Q; Huang S; Liu B; Wu D
BJU Int; 2012 Dec; 110(11 Pt C):E1125-30. PubMed ID: 22672360
[TBL] [Abstract][Full Text] [Related]
18. Knockdown of COPS3 inhibits the progress of prostate cancer through reducing phosphorylated p38 MAPK expression and impairs the epithelial-mesenchymal transition process.
Zhu Z; Hong Y; Zhang F; An L; Yang Q; Huang X; Xu Q
Prostate; 2019 Dec; 79(16):1823-1831. PubMed ID: 31509289
[TBL] [Abstract][Full Text] [Related]
19. PPM1D as a novel biomarker for prostate cancer after radical prostatectomy.
Jiao L; Shen D; Liu G; Jia J; Geng J; Wang H; Sun Y
Anticancer Res; 2014 Jun; 34(6):2919-25. PubMed ID: 24922655
[TBL] [Abstract][Full Text] [Related]
20. Sea cucumber extract TBL-12 inhibits the proliferation, migration, and invasion of human prostate cancer cells through the p38 mitogen-activated protein kinase and intrinsic caspase apoptosis pathway.
Yuan L; Huang X; Zhou K; Zhu X; Huang B; Qiu S; Cao K; Xu L
Prostate; 2019 Jun; 79(8):826-839. PubMed ID: 30889629
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]